Literature DB >> 20455047

[A 25-year-old patient with colonic pseudo-obstruction, hyponatremia, hypertension, and diffuse pain].

Philipp Lutz1, Daniel Maring, Henriette J Tschampa, Tilman Sauerbruch.   

Abstract

CASE REPORT: A 25-year-old hypertensive patient presented to the Emergency Department with constipation and diffuse pain which had been increasing for 10 days. She had consulted several doctors before, but neither various analgesics nor metoclopramide had been beneficial. Blood analysis showed hyponatremia. A megacolon and polyneuropathy were found. Shortly after admission, she developed generalized seizures while hyponatremia increased compatible with SIADH (syndrome of inadequate ADH secretion). Urine examination revealed a markedly elevated excretion of porphyrins. Since porphobilinogen deaminase activity was clearly decreased, diagnosis of acute intermittent porphyria could be confirmed.
CONCLUSION: This case shows how definite diagnosis of this illness is often delayed because of its rarity and the variety of its possible symptoms and signs. This delay leads to a high risk of aggravating the disease by prescribing porphyrinogenic drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20455047     DOI: 10.1007/s00063-010-1047-1

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  25 in total

1.  Acute hepatic porphyrias and primary liver cancer.

Authors:  C Andant; H Puy; J Faivre; J C Deybach
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

2.  Mortality in patients with acute intermittent porphyria requiring hospitalization: a United States case series.

Authors:  J B Jeans; K Savik; C R Gross; M K Weimer; I C Bossenmaier; C A Pierach; J R Bloomer
Journal:  Am J Med Genet       Date:  1996-11-11

Review 3.  The hyponatremic patient: a systematic approach to laboratory diagnosis.

Authors:  Haralampos J Milionis; George L Liamis; Moses S Elisaf
Journal:  CMAJ       Date:  2002-04-16       Impact factor: 8.262

4.  Acute intermittent porphyria: effect of diet and griseofulvin.

Authors:  B F Felsher; A G Redeker
Journal:  Medicine (Baltimore)       Date:  1967-03       Impact factor: 1.889

5.  Acute intermittent porphyria presenting as a diffuse encephalopathy.

Authors:  Boby V Maramattom; Renzo A Zaldivar; Simon M Glynn; Scott D Eggers; Eelco F M Wijdicks
Journal:  Ann Neurol       Date:  2005-04       Impact factor: 10.422

6.  A sensitive method of screening for urinary porphobilinogen.

Authors:  J E Buttery; B R Chamberlain; C G Beng
Journal:  Clin Chem       Date:  1989-12       Impact factor: 8.327

7.  Hypertension and renal impairment as complications of acute porphyria.

Authors:  S E Church; K E McColl; M R Moore; G R Youngs
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

8.  Liver transplantation as a cure for acute intermittent porphyria.

Authors:  Zahir F Soonawalla; Taner Orug; Michael N Badminton; George H Elder; Jonathan M Rhodes; Simon R Bramhall; Elwyn Elias
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

9.  Alterations in haem biosynthesis during the human menstrual cycle: studies in normal subjects and patients with latent and active acute intermittent porphyria.

Authors:  K E McColl; A M Wallace; M R Moore; G G Thompson; A Goldberg
Journal:  Clin Sci (Lond)       Date:  1982-02       Impact factor: 6.124

10.  Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria.

Authors:  J S Lee; M Anvret
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.